Overview
Pradaxa Capsules contain Dabigatran Etexilate 150 mg, an oral anticoagulant that helps prevent and treat blood clots by inhibiting thrombin, an enzyme essential for blood coagulation. It is widely prescribed for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).





